The Journal of Spinal Cord Medicine, 2024 · DOI: 10.1080/10790268.2021.2014234 · Published: January 1, 2024
This study compares conventional surgery with cellular therapy (infusion of bone marrow mononuclear cells) for treating pressure injuries (PIs) in patients with spinal cord injuries. The study found that while cellular therapy showed promise initially, conventional surgery proved more effective in the medium to long term for PI treatment. The research suggests that bone marrow mononuclear cell infusion-infiltration could be an alternative treatment for PIs during the first 6 months, but conventional surgery is more effective later on.
Consider conventional surgery as the primary treatment for pressure injuries in spinal cord injury patients due to its long-term effectiveness.
Bone marrow mononuclear cell infusion-infiltration may be considered as an alternative for short-term treatment (first 6 months) of PIs.
Cell therapy may contribute to faster recovery, potentially resulting in a shorter hospital stay, particularly in the initial postoperative months.